DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Hayashi M, Jono H, Shinriki S, Nakamura T, Guo J, Sueta A. et al.
Clinical significance of CYLD downregulation in breast cancer.
Breast cancer research and treatment 2014;
143: 447-457
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.